Abstract Three new lycodine-type Lycopodium alkaloids, namely 1-methyllycodine (1), 8a-hydroxy-15,16-dehydro-des-N-methyl-a-obscurine (2), N-methyl-16-hydroxyhuperzine B (3), and one new natural lycodine-type Lycopodium alkaloid, N-methylhuperzine A (4), along with 11 known analogues (5-15), were isolated from the whole plants of club moss Huperzia serrata. The structures of 1-4 were elucidated on the basis of NMR spectroscopic and mass spectrometry data. Among them, compound 1 was the first lycodine-type alkaloid possessing a methyl group at C-1. In addition, the structure of 5 was confirmed by the single-crystal X-ray crystallography data and its 13 C NMR was reported for the first time in current study. Compounds 1-5 were tested their BACE1 inhibitory activity. 
have attracted broad interest from chemists and pharmacologists worldwide due to their intriguing carbon skeletons and biological activities [1] [2] [3] [4] [5] [6] . Such alkaloids were divided into four major classes (lycopodine, lycodine, fawcettimine, and phlegmarine) by Canadian famous chemists Ayer et al. [7] . Particularly, lycodine-type alkaloids, which generally characterized by four connected sixmembered rings, including a pyridone or pyridine ring, a piperidine ring, and a bicyclo[3.3.1]nonane core [8] , are a unique class of compounds and have attracted great interest for their biological activities especially the extraordinary acetylcholinesterase (AChE) inhibition by huperzine A that has a potential of becoming a therapeutic agent for the treatment of Alzheimer's disease [2, 9] . Chinese traditional medicinal plant Huperzia serrata, chiefly growing in rock crevice or somewhere dank in the forests, shrubs, or roadsides at the elevation of 300-2700 m in Southwestern and Southeastern China, belonged to the Huperziaceae family and was known for its therapeutic effect on contusions, pains, swellings, schizophrenia, and organophosphate poisoning in ancient China [10, 11] . Previously, phytochemical studies on H. serrata have led to a series of components [12, 13] . Among them, lycodinetype Lycopodium alkaloids were its main chemical and bioactive ingredients [14, 15] , in particular, a type of alkaloids that possessed extraordinary AChE inhibition, such as the well-known huperzine A [2, 9] . As part of an ongoing research program aimed at exploring more Lycopodium alkaloids with fascinating structures and bioactivities serving as lead compounds for drug discovery, three new lycodine-type alkaloids, 1-methyllycodine (1), 8a-hydroxy-15,16-dehydro-des-N-methyl-a-obscurine (2) , Nmethyl-16-hydroxyhuperzine B (3), and one new natural Lycopodium alkaloid N-methylhuperzine A (4) were isolated from H. serrata (Fig. 1) , together with 11 known analogues. The known compounds were identified as 6b-hydroxyhuperzine A (5) [16] , huperzine A (6) [2, 9] , huperzine B (7) [2, 9] , casuarine B (8) [17] , huperzinine (9) [18] , lycodine (10) [19] , N-methyllycodine (11) [20, 21] , carinatumine B (12) [22] , des-N-methyl-b-obscurine (13) [23] , N-demethylhuperzinine (14) [24] , and 16-hydroxyhuperzine B (15) [25] by comparison of their spectroscopic data with those reported in the literature. Their structures were determined by extensive spectroscopic analysis. Among them, the structure of 5 was confirmed by the single-crystal X-ray crystallography data ( Fig. 2) and its 13 C NMR data (Table 2) was reported for the first time in current study. In addition, these findings might provide more information for the biological activities study and synthesis of lycodine-type alkaloids. Reported herein are the isolation, structure elucidation and bioactivity investigation results of compounds 1-5.
Results and Discussion
The air-dried and powdered whole plants of H. serrata were extracted with 60% EtOH for three times. The extract was partitioned between EtOAc and 1.0% HCl/H 2 O. Water-soluble materials, which were adjusted to pH 9 with 17% ammonia solution, were then extracted with CHCl 3 to afford an alkaloidal extract. Further column chromatography (CC) over MCI gel, normal-phase silica gel, and Sephadex LH-20 led to the isolation of three new lycodinetype alkaloids (1-3), one new natural lycodine-type Lycopodium alkaloid (4), together with 11 known ones (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . (Fig. 3) , as well as the obvious triplet signal of H-1 in 10 was disappeared in 1. It is worth noting that 1 was the first lycodine-type Lycopodium alkaloid possessing a methyl group at C-1. The relative configuration of 1 was deduced by the ROESY experiment (Fig. 3) and the coupling constant. Biogenetially, H-12 and H-7 of the lycodine-type Lycopodium alkaloids were b-and a-orientated, respectively, which were also supported by the diagnostic ROESY correlations of H-6a with H-11b and H-7 with H-11a. Irradiation of H-12 enhanced the signal of H-14a, indicating that these protons were on the same facial plane. Furthermore, the methyl group at C-15 was located at an equatorial position by the large coupling constant (11.9 Hz) between H-14a and H-15. Thus, the structure of 1 was determined and named as 1-methyllycodine. Tables 1, 2) showed general features analogous to those of des-N-methyl-a-obscurine [23, 27] . Differing from the latter, compound 2 has one more hydroxy group and a D In the ROESY spectrum (Fig. 4) , the b-and a-orientation of H-12 and H-7, respectively, were revealed by the observed correlations of H-6a/H-11b, H-7/H-11a, and H-12/H-14b. Furthermore, the obvious ROESY correlation of H-8/H-6b allowed the assignment of OH-8 as a-orientated. On the basis of the above evidence, the structure of 2 was assigned as 8a-hydroxy-15,16-dehydro-des-N-methyla-obscurine.
Compound 3 showed the pseudo-molecular ion peak at m/z 287. 13 C NMR, and DEPT spectra (Tables 1, 2) . Analysis of the 1D NMR spectra of 3 revealed that its spectroscopic data closely resembled those of 16-hydroxyhuperzine B (15) [25] , a known lycodine-type alkaloid previously isolated from Lycopodium casuarinoides. The only difference between those two compounds was that 3 possessed an additional Nmethyl group. Consequently, compound 3 was assumed to be the N-methylated derivative of 16-hydroxyhuperzine B, which was confirmed by observed key HMBC correlations from N-methyl (H-17) at d H 2.69 to C-9 (d C 51.8) and C-13 Table 1) . The above data allowed 4 to be a N-methyl derivative of huperzine A, which was confirmed by the observed key HMBC correlation between the proton at d H 2.09 with the sp 3 quaternary carbon C-13 at d C 61.1 (Fig. 5) . The observed ROESY correlations (Fig. 5 ) of H-6b/H-8 and of H-7/H-10 (d H 1.71) indicated that H-7 was a-orientated. The R * configuration of C-13 was assigned by the clear ROESY correlations of H-3 with H-14a and H-11 with H-17. Accordingly, the structure of 4 was characterized as N-methylhuperzine A, which reported previously as a synthetic product from the methylation of huperzine A [2, 9] . To our knowledge, compound 4 was isolated for the first time from natural resources.
Compounds 1-5 were evaluated for their b-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1) inhibitory activity. Unfortunately, the results showed that all the compounds were inactive (IC 50 values [100 lM).
Experimental Section

Gernal Experimental Procedures
UV spectra were recorded with a Shimadzu UV-2401A spectrophotometer. IR spectra were recorded on Bruker Tensor 27 spectrometer with KBr pellets. 1D and 2D NMR spectra were carried out on Bruker AM-400, DRX-500, or AVANCE III-600 spectrometers. Chemical shifts were reported using TMS as the internal standard. ESI-MS were run on Shimadzu UPLC-IT-TOF-MS instrument. HR-ESI-MS spectra were measured using Agilent G 6230 TOF MS (Agilent). EI-MS and HR-EI-MS spectra were measured with a Waters AutoSpec Premier P776 mass spectrometer (Waters, Milford, MA, USA).Crystal analysis were performed on a Bruker APEX DUO diffractometer equipped with an APEX II CCD, using Cu Ka radiation (k = 1.54178 Å ). Cell refinement and data reduction were performed with Bruker SAINT. Column chromatography (CC) was performed on silica gel (100-200 or 200-300 mesh; Qingdao Marine Chemical Co. Ltd., Qingdao, China), Sephadex LH-20 (GE Healthcare Bio-Sciences AB, Sala, Sweden) and MPLC was performed on a Lisui EZ Purify III System packed with MCI gel (CHP20P, 75-150 mm; Mitsubishi Chemical Corporation, Tokyo, Japan). Precoated silica gel GF254 plates (Qingdao Haiyang Chemical Co. Ltd.) were used for thinlayer chromatography (TLC). Fractions were monitored by TLC and spots were visualized by Dragendorff's reagent.
Plant Material
The club moss H. serrata was collected from Taijiang County, Guizhou Province, People's Republic of China in July, 2012. The plant was identified by one of the authors, Prof. Lu-Tai Pan (Guiyang College of Traditional Chinese Medicine). And the voucher specimen (No. 20120312h) was deposited at the State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences.
Extraction and Isolation
The aerial parts of club moss H. serrata (40 kg) were chopped into sections and extracted with 60% EtOH/H 2 O under reflux for three times (24 h 9 3). The resultant extract was partitioned between EtOAc and 1% HCl/H 2 O solution to afford ethyl acetate and water soluble fractions, respectively. The water-soluble fractions were adjusted to pH 9 with 17% ammonia solution, and then extracted with CHCl 3 to give an alkaloidal extract (106 g). The alkaloidal extract was subjected to a MCI gel CC (MeOH/H 
X-ray Crystal Structure Analysis
Crystal analysis were performed on a Bruker APEX DUO diffractometer equipped with an APEX II CCD, using Cu Ka radiation (k = 1.54178 Å ). Cell refinement and data reduction were performed with Bruker SAINT. The structure of 5 was solved by direct methods using SHELXS-97. Refinements were performed with SHELXL-97 using full-matrix least-squares, with anisotropic displacement parameters for all the non-hydrogen atoms. The H-atoms were placed in calculated positions and refined using a riding model. Crystallographic data for 5 in this paper have been deposited with the Cambridge Crystallographic Data Centre (CCDC 1518517). Copies of the data can be obtained free of charge from the CCDC via www. ccdc.cam.ac.uk. 
BACE1 Inhibitory Activity Assay
Compounds 1-5 were assessed for b-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1) inhibitory activity. BACE1 inhibitory evaluation was tested using a fluorescence resonance energy transfer (FRET) assay kit supplied by PanVera (Kit P2985, Madison, WI, USA). The kit was using purified baculovirus expression BACE1 and substrates of a new red FRET peptide substrates, which were based on the ''Swedish'' mutation. The BACE1 FRET assay was carried out according to the principle described in Ref. [26] . The first orally available non-peptidic b-secretase inhibitor LY2811376, [28] which had an IC 50 value of 401.21 nM, was using as a positive control.
